Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD). It contains an inhaled corticosteroid called budesonide ...
Viatris announced the launch of Breyna ™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of AstraZeneca’s Symbicort ®. Breyna is a metered-dose inhaler ...
Symbicort, which is used to treat chronic obstructive pulmonary disease and asthma, can cause side effects. Mild side effects include nasal congestion and headaches. Serious side effects include ...
Iconovo, which develops complete inhalation products for a global market, is expanding its collaboration with Amneal for Symbicort in the ICOres inhaler to include additional territories with a ...
LONDON, Oct 18 (Reuters) - AstraZeneca Plc lost a key European patent on its two-in-one asthma drug Symbicort on Thursday but the drugmaker said it did not expect the move to have an immediate impact ...
(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...
PITTSBURGH and ST. PAUL, Minn., March 8, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted ...
Mylan's proposed generic version of AstraZeneca's billion-dollar asthma drug gets another shot in patent case Lower court misinterpreted patents' terms, said divided Federal Circuit (Reuters) - Mylan ...
Wilmington, DE – May 22, 2007 – New data demonstrated that the combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dihydrate), led to ...
Wilmington, DE – June 4, 2008 – AstraZeneca (NYSE: AZN) today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...
If you have a certain kind of breathing condition, your doctor might suggest Symbicort as a treatment option. It’s a prescription drug used to treat the following: chronic obstructive pulmonary ...
Viatris and Kindeva Drug Delivery announced that they have won a significant court decision in which the U.S. District Court for the Northern District of West Virginia found that AstraZeneca's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback